Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
Q2 2016
|
TNXP |
|
Phase 2 Results |
Neurology |
None |
|
Q4 2016
|
MDVN |
|
Phase 3 Results |
Oncology |
None |
|
10/22/2016
|
MDVN |
|
PDUFA |
Oncology |
None |
|
12/11/2016
|
SPPI |
|
PDUFA |
Oncology |
None |
|
10/14/2016
|
EGLT |
|
PDUFA |
Neurology |
None |
|
Q3 2016
|
GNCA |
|
Phase 2b Results |
Infectious Disease |
None |
|
09/15/2016
|
DVAX |
|
PDUFA |
Infectious Disease |
None |
|
Q2 2016
|
RIGL |
|
Phase 3 Results |
Autoimmune |
None |
|
Q3 2016
|
RIGL |
|
Phase 3 Results |
Autoimmune |
None |
|
Q4 2016
|
RIGL |
|
Phase 2 Results |
Autoimmune |
None |
|